Teriflunomide normalizes anti-anxiety effect in anti-ANXA2 APS mice model teriflunomide in anti-ANXA2 mice model

Autor: Ofir Zmira, Shany Guly Gofrit, Shay Anat Aharoni, Ronen Weiss, Efrat Shavit-Stein, Joab Chapman

Publikováno v: Lupus. 31:855-863

Antiphospholipid syndrome (APS) affects the brain by both hypercoagulation and immunological mechanisms. APS is characterized by several autoantibodies binding to a thrombolytic complex including beta-2-glycoprotein I (β2-GPI) and annexin A2 (ANXA2)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4effaac36759562836bdcd4fbc2f4fe
https://doi.org/10.1177/09612033221095150

List of contributors

Autor: Yekbun Adiguzel, Laura Andreoli, Eleonora Antonelli, Lambros Athanassiou, Panagiotis Athanassiou, Tadej Avčin, Nina Babel, Nicole Bechmann, Carina Benzvi, Victoria Bitsadze, Dimitrios P. Bogdanos, Srinivsasa Reddy Bonam, Vânia Borba, M.O. Borghi, Stefan R. Bornstein, Nicola Luigi Bragazzi, Pedro Carrera-Bastos, Leonid P. Churilov, Francesca Crisafulli, María Pilar Cruz-Domínguez, M. Cugno, MariaGiovanna Danieli, Efthymios Dardiotis, Paula David, Tal Davidy, Silvia-Ebe-Lucia Della-Pina, Arad Dotan, Marie-Agnès Dragon-Durey, Georgios Efthymiou, Michael Ehrenfeld, Ismail Elalamy, Nina Emeršič, Kamaeva Evelina, Giulia Fontana, Franco Franceschini, Véronique Fremeaux-Bacchi, Marvin J. Fritzler, Maria F. Galaviz-Sánchez, K.K. Ganina, Natalia Gavrilova, Roberto Giacomelli, Jean-Christophe Gris, Caroline I. Gutierrez-Melgarejo, Ehud Horwitz, Eitan Israeli, Etienne Jacotot, Luis J. Jara, Darja Kanduc, Christoph Kessel, Jamilya Khizroeva, Andrei Kolobov, Ifigenia Kostoglou-Athanassiou, Sergey V. Lapin, G. Lasagni, Aaron Lerner, Danielle Zemer Lev, Soprun Lidiia, Berenice López-Zamora, Jose Manuel Lozano, Abihai Lucas Hernández, Alexander Makatsariya, Anna Malkova, Lukashenko Maria, Margarita A. Mayorova, Gabriela Medina, P.L. Meroni, Dror Mevorach, Sylviane Muller, Natalia N. Petrova, Vladimir N. Nikolenko, Alberto Ordinola Navarro, Irvin Ordoñez-González, Alberto Paladini, Margarita Y. Pervakova, Ofer Perzon, N.V. Petrova, Marko Radic, Eirini I. Rigopoulou, Jorge-Manuel Rodrigues-Fernandes, Avi Rosenberg, Piero Ruscitti, Varvara A. Ryabkova, Rafael Simone Saia, Sergey V. Sankov, Maria V. Sankova, Yehuda Shoenfeld, Mikhail Y. Sinelnikov, Polina Sobolevskaia, Ulrik Stervbo, Laura Talamini, S.A. Tarasov, Lorenz Thurner, Angela Tincani, Olga Y. Tkachenko, M. Tocut, Francesco Ursini, Olga Vera-Lastra, Angelica Thomaz Vieira, Aristo Vojdani, Elroy Vojdani, Abdulla Watad, G. Zandman-Goddard, Ofir Zmira, Daniela Noa Zohar

Publikováno v: Autoimmunity, COVID-19, Post-COVID19 Syndrome and COVID-19 Vaccination ISBN: 9780443185663

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::13a92fa8b0202f7a34025c23b852f4ec
https://doi.org/10.1016/b978-0-443-18566-3.01002-1

Autoantibodies to Annexin A2 and cerebral thrombosis: Insights from a mouse model

Autor: Joab Chapman, Itai Benhar, Valery Golderman, Tali Drori, Ekaterina Mindel, Ronen Weiss, Yael Diesendruck, Shay Anat Aharoni, David Orion, Doron Bushi, Efrat Shavit-Stein, Ofir Zmira, Orna Gera, Nancy Agmon-Levin, Almog Bitton, Oren Kashi

Publikováno v: Lupus

Introduction Antiphospholipid syndrome (APS) is an autoimmune disorder manifested by thromboembolic events, recurrent spontaneous abortions and elevated titers of circulating antiphospholipid antibodies. In addition, the presence of antiphospholipid

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f0c105b255483193835762fd87304d3
https://pubmed.ncbi.nlm.nih.gov/33554716

Parkinson's disease phenotype is influenced by the severity of the mutations in the GBA gene

Autor: Nir Giladi, Tamara Shiner, Avi Orr-Urtreger, Tanya Gurevich, Ziv Gan-Or, Yonatan Dror, Mali Gana-Weisz, Noa Bregman, Avner Thaler, Ofir Zmira, Anat Mirelman, Anat Bar-Shira

Publikováno v: Parkinsonism & Related Disorders. 55:45-49

Mutations in the glucocerebrosidase (GBA) gene are divided into mild and severe (mGBA, sGBA) based on their contribution to the phenotype of Gaucher disease (GD) among homozygotes. We conducted a longitudinal analysis of Parkinson's disease (PD) pati

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73ce62c83c1bb07e256f7b21ef2b250d
https://doi.org/10.1016/j.parkreldis.2018.05.009

Efficacy of alemtuzumab treatment in active RRMS - a real-life study

Autor: Ofir zmira

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::84b19ada8e93928d92ab8648765413dd
https://doi.org/10.26226/morressier.5b719e475aff74008ae4cba9